Recap: Biolase Q4 Earnings

Biolase BIOL reported its Q4 earnings results on Thursday, March 21, 2024 at 04:05 PM.

Here's what investors need to know about the announcement.

Biolase beat estimated earnings by 31.0%, reporting an EPS of $-1.76 versus an estimate of $-2.55.

Revenue was down $561 thousand from the same period last year.

Last quarter the company missed on EPS by $2.04 which was followed by a 20.0% drop in the share price the next day.

Here's a look at Biolase's past performance:

Quarter	Q3 2023	Q2 2023	Q1 2023	Q4 2022
EPS Estimate	-1.85	-5.33	-20	-64
EPS Actual	-3.89	-4.24	-18	-128
Revenue Estimate	13.96M	15.36M	10.18M	14.07M
Revenue Actual	10.92M	14.29M	10.47M	14.05M

To track all earnings releases for Biolase visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar